Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
Cited by 18
Related Papers
Alternative splicing and cancer: a systematic review
|Signal Transduction and Targeted Therapy|2021|489
NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
|Oncotarget|2014|72
CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
|Molecular Cancer|2021|72
BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability
|Signal Transduction and Targeted Therapy|2021|68
AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|32